tradingkey.logo
搜索

Bioventus Inc

BVS
添加自选
10.480USD
+0.630+6.40%
收盘 07/02, 13:00美东报价延迟15分钟
703.18M总市值
24.52市盈率 TTM

Bioventus Inc

10.480
+0.630+6.40%
查看详细走势图
TradingKey 图表
盘中分时
1分
30分
1小时
日k
周k
月k
日k

今天

+6.40%

5天

+7.16%

1月

+20.46%

6月

+45.35%

今年开始到现在

+40.86%

1年

+49.29%

关键数据
9.968今开
10.489最高
701.20K成交量
24.52市盈率 TTM
9.92市盈率动
--股息TTM
1.05%换手率
9.850昨收
9.880最低
5.19M成交额
亏损市盈率静
3.82市净率
0.00%股息率 TTM
5.15%ROA
11.24952周最高
1.43量比
-33.54M净利润
67.10M总股本
0.4274每股收益TTM
0.69Beta
16.90%ROE
5.81052周最低
6.18%振幅
67.88%毛利率
703.18M总市值
4.56回报/风险
2.90%风险率

TradingKey Bioventus Inc股票评分

单位: USD 更新时间: 2026-07-02

操作建议

Bioventus Inc当前公司基本面数据相对非常健康,增长潜力很大。当前估值合理,在医疗设备与耗材行业排名49/204位。机构持股占比非常高,近一月多位分析师给出公司评级为买入。最高目标价14.80。中期看,股价处于上升通道。近一个月,市场表现很强,技术面和基本面综合得分较高,很强的走势得到基本面和技术面的印证。目前股价在压力位和支撑位之间,可以做区间波段操作。

Bioventus Inc评分

相关信息

行业排名
49 / 204
全市场排名
129 / 4565
所属行业
医疗设备与耗材

压力支撑

由于公司未披露,未能获取相关数据

多维评测

本期评分
上期评分

公司舆情

过去24小时
热度

过冷
过热
极度看空

Bioventus Inc亮点

亮点风险
Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
业绩转盈
公司业绩转盈,最新年度盈利美元
估值高估
公司最新PE估值24.52,处于3年历史高位
机构减仓
最新机构持股52.51M股,环比减少16.27%
查克·罗伊斯持仓
明星投资者查克·罗伊斯持仓,最新持仓市值1.58M
活跃度增加
近期活跃度增加,过去20天平均换手率0.66

分析师目标

根据 5 位分析师
买入
评级
14.800
目标均价
+50.25%
涨幅空间

Bioventus Inc新闻

即将为您带来更多新闻,敬请期待。。。

财务指标

每股收益

由于公司未披露,未能获取相关数据

营业总收入

由于公司未披露,未能获取相关数据

Bioventus Inc简介

Bioventus Inc. is a medical device company. The Company’s portfolio of products is grouped into three areas. Its Pain Treatments include the Knee Osteoarthritis (KOA) area, and Peripheral Nerve Stimulation (PNS) area. Its Surgical Solutions include Ultrasonics, which offers precision bone resection for patients with degenerative spine conditions and spinal deformities, and Bone Graft Substitutes (BGS), which includes a range of products that facilitate optimal bone fusion following a surgical procedure. Its Restorative Therapies comprise Fracture Care that provide low-intensity pulse ultrasound to help patients who suffer from bone fractures that do not heal through traditional methods. It offers a diverse portfolio of products to support physicians in relieving pain and addressing musculoskeletal challenges across indications and clinical areas, including knee, hand and upper extremities, foot and ankle, podiatry, trauma, general surgery, spine and neurosurgery.
公司代码BVS
公司Bioventus Inc
CEOClaypoole (Robert E)
网址https://www.bioventus.com/

常见问题

Bioventus Inc(BVS)的当前股价是多少?

Bioventus Inc(BVS)的当前股价是 10.48。

Bioventus Inc的股票代码是什么?

Bioventus Inc的股票代码是BVS。

Bioventus Inc股票的52周最高点是多少?

Bioventus Inc股票的52周最高点是11.25。

Bioventus Inc股票的52周最低点是多少?

Bioventus Inc股票的52周最低点是5.81。

Bioventus Inc的市值是多少?

Bioventus Inc的市值是708.86M。

现在Bioventus Inc(BVS)的股票是买入、持有还是卖出?

根据分析师评级,Bioventus Inc(BVS)的总体评级为买入,目标价格为14.80。

Bioventus Inc(BVS)股票的每股收益(EPS TTM)是多少

Bioventus Inc(BVS)股票的每股收益(EPS TTM)是0.34。